2013 Program

Workshop Chairs:
Mark Tuominen, Director, National Nanomanufacturing Network
Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network

The Supreme Court has been subjecting US patents to heightened scrutiny in cases like Myriad, where it struck down a claim covering a “product of nature.” Another round of legislative changes to US patent law has further complicated patent planning for companies. Against a backdrop of heightened judicial scrutiny and changing laws, nanotech companies need to build long-term patent portfolios that protect investors, yet are flexible enough to protect future product designs or even completely different application areas than those envisioned by company founders. The long product development cycles for nanotech make it especially hard to build a patent portfolio that will satisfy these objectives. Panelists will provide insights into how nano innovators can meet these challenges and profit from opportunities created by the changing US patent environment. Among other topics, panelists will discuss:

• What are the current trends in nanotech patenting at the US Patent Office?
• What kinds of patents can safely withstand Supreme Court scrutiny today?
• What opportunities have been created for avoiding competitor patents under the new laws and court decisions?
• How can a patent portfolio cover future changes to product designs and new application areas?

Moderator: Steve Maebius, Partner, Foley & Lardner LLP
Speakers: Andrew Baluch, Special Counsel, Foley & Lardner LLP
Hans Sauer, Ph.D., JD, Associate General Counsel for Intellectual Property, BIO
Jerry Lorengo, Director of Technology Center 1600, USPTO

Lynn L. Bergeson, Managing Director, Bergeson & Campbell, P.C.

Dr. Jeffrey Morse, Managing Director, National Nanomanufacturing Network
Vincent Caprio, Executive Director, NanoBusiness Commercialization Association

A Revolution in the Treatment of Metastatic Cancer
Steve Klemm, Chief Scientific Officer, Leonardo Biosystems Inc.

Cluster university R&D investments into a research center around a specific science or engineering opportunity and a vibrant innovation economy will result, right? Not likely. Most NSF, NIH or even state-funded university research centers do not maximize their regional economic outcome potential. Well-designed research centers, though, can help bring an innovation ecosystem together through increased attracted R&D funding, the spillover effects of knowledge dissemination, student learning experiences, local early access to new technologies, and, yes, even more successful companies and local job creation. In this practitioner-focused session, we’ll examine innovative research centers taking more holistic approaches to help bring innovation ecosystems together – and the lessons they’ve learned on what works and what doesn’t.

Presenters:
The Role of Research Centers in the Nanotechnology Innovation Ecosystem
Anthony P. Green, Vice President, Technology Commercialization Group - Life Sciences and Ben Franklin Director, The Nanotechnology Institute & Energy Commercialization Institute

From (nano)Technology Push to Market Pull: the ONAMI Model
Robert. D. "Skip" Rung, President and Executive Director, Oregon Nanoscience and Microtechnologies Institute

Utilizing the Oregon Startup Ecosystem
Dr. Wei Wang, Research Scientist, Amorphyx, Inc.
Dr. Sean Muir, Senior Research Scientist, Amorphyx, Inc.

Sponsored by

Reception
Located at the Singh Nanotechnology Center

Greeting: Mark G. Allen, Ph.D., Scientific Director, Krishna Singh Center for Nanotechnology, Professor, Department of Electrical & Systems Engineering, School of Engineering & Applied Sciences, University of Pennsylvania

David E. Reisner, Ph.D., Founder, Director, International Sales Leader, The Nano Group, Inc.

Jeffrey H. Rosedale, Partner, Woodcock Washburn LLP

Risk Management and Minimizing Legal Exposure
Michael J. Sullivan, Partner, Womble, Carlyle, Sandridge and Rice

Product Stewardship for Nanotechnology Products: Current Regulations and Risk Management
Linda D. Dell, MS, Senior Science Manager; Environ Corp.

Moderator: Dr Alan Rae, Co-founder, Graphene Stakeholders Association

Graphene Measurement and Standards
Dr. Andrew Pollard, Research Scientist, National Physical Laboratory

Metrology Solutions for 2-D Nanomaterials
Dr. Toby Sainsbury, Research Scientist, National Physical Laboratory

Dr. Angela Hight Walker, Senior Scientist, NIST

Moderator: Keith Blakely, Co-founder, Graphene Stakeholders Association

Graphene and Beyond: Recent Progress in the Production of 2D Materials
Dr. Elena Polyakova, Founder and CEO, Graphene Labs

Commercialisation of Graphenes
Ray Gibbs, Commercial Director, Haydale

John Biondi, CEO, Xolve Inc.

Materials Science has been integral to the advancement of mankind since time immemorial. Because of the many advances these technologies have introduced, we’re generally accustomed to an ever-increasing continuum of change while also accepting the inherent risks that occur. With nanotechnology, however, society has taken a somewhat tempered approach to this progress and balanced benefit against a notably more cautious approach. This is evidenced by the National Nanotechnology Initiative which mandates that Occupational, Environmental, Health and Safety (OEHS) be as critical a component to the science of nanotechnology as the materials sciences in which it exists. The presentation offered here will provide participants with a global overview of current good practices associated with Nanotechnology OEHS and detail those programs under development to minimize and control these unique risks.

Donald Ewert, IH, VP-Field Services, nanoTox, Inc.
Moderator: Vincent Caprio, Executive Director, NanoBusiness Commercialization Association

Moderator: Stephen Waite, Co-founder, Graphene Stakeholders Association

Graphene Frontiers
Mike Patterson, CEO, Graphene Frontiers

High Performance Products Powered by Graphene
Jon Myers, CEO, Graphene Technologies

The ability to manipulate cells and microparticles in a biocompatible and dexterous manner is critical for numerous biological studies and applications such as cell-cell communication, biosensing, tissue engineering, and regenerative medicine. Here we summarize our recent progress on an “acoustic tweezers” technique that utilizes standing surface acoustic wave (SSAW) to manipulate particles, cells, and organisms. This technique is capable of manipulating cells and microparticles regardless of shape, size, charge or polarity. Its power intensity, approximately 107 times lower than that of optical tweezers, compares favorably with those of other active patterning methods. Cell viability, proliferation, and apoptosis studies have revealed the technique to be biocompatible. The aforementioned advantages, along with this technique’s simple design and ability to be miniaturized, render the “acoustic tweezers” technique a promising tool for various applications in biology, chemistry, engineering, and materials science.

Prof. Tony Jun Huang, CTO, Ascent Bio-Nanotechnologies, Inc.